352 related articles for article (PubMed ID: 18553082)
1. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
[TBL] [Abstract][Full Text] [Related]
2. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.
Gori E; Arpinati M; Bonifazi F; Errico A; Mega A; Alberani F; Sabbi V; Costazza G; Leanza S; Borrelli C; Berni M; Feraut C; Polato E; Altieri MC; Pirola E; Loddo MC; Banfi M; Barzetti L; Calza S; Brignoli C; Bandini G; De Vivo A; Bosi A; Baccarani M
Bone Marrow Transplant; 2007 Mar; 39(6):347-52. PubMed ID: 17277790
[TBL] [Abstract][Full Text] [Related]
3. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.
Kashiwazaki H; Matsushita T; Sugita J; Shigematsu A; Kasashi K; Yamazaki Y; Kanehira T; Kondo T; Endo T; Tanaka J; Hashino S; Nishio M; Imamura M; Kitagawa Y; Inoue N
Support Care Cancer; 2012 May; 20(5):933-9. PubMed ID: 21494780
[TBL] [Abstract][Full Text] [Related]
4. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
Vokurka S; Bystricka E; Scudlova J; Mazur E; Visokaiova M; Vasilieva E; Brandejsova R; Chvojkova I; Vrabcova M; Vitkova J; Mjartanova D; Vodickova M; Bockova J; Streinerova K
Eur J Oncol Nurs; 2011 Dec; 15(5):508-12. PubMed ID: 21310656
[TBL] [Abstract][Full Text] [Related]
5. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
6. A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation.
Elad S; Ackerstein A; Bitan M; Shapira MY; Resnick I; Gesundheit B; Cohen Y; Diss O; Barak D; Dray L; Or R
Bone Marrow Transplant; 2006 Apr; 37(8):757-62. PubMed ID: 16518424
[TBL] [Abstract][Full Text] [Related]
7. Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen.
Kojima R; Kami M; Nannya Y; Kusumi E; Sakai M; Tanaka Y; Kanda Y; Mori S; Chiba S; Miyakoshi S; Tajima K; Hirai H; Taniguchi S; Sakamaki H; Takaue Y
Biol Blood Marrow Transplant; 2004 Sep; 10(9):645-52. PubMed ID: 15319776
[TBL] [Abstract][Full Text] [Related]
8. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.
Grazziutti ML; Dong L; Miceli MH; Krishna SG; Kiwan E; Syed N; Fassas A; van Rhee F; Klaus H; Barlogie B; Anaissie EJ
Bone Marrow Transplant; 2006 Oct; 38(7):501-6. PubMed ID: 16980998
[TBL] [Abstract][Full Text] [Related]
9. Low-energy laser therapy for prevention of oral mucositis in hematopoietic stem cell transplantation.
Jaguar GC; Prado JD; Nishimoto IN; Pinheiro MC; de Castro DO; da Cruz Perez DE; Alves FA
Oral Dis; 2007 Nov; 13(6):538-43. PubMed ID: 17944669
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation.
Bhatt V; Vendrell N; Nau K; Crumb D; Roy V
J Oncol Pharm Pract; 2010 Sep; 16(3):195-204. PubMed ID: 19910393
[TBL] [Abstract][Full Text] [Related]
12. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.
Bolwell BJ; Kalaycio M; Sobecks R; Andresen S; Kuczkowski E; Bernhard L; Lomax R; Kohuth J; Mendiola S; Rybicki L; Pohlman B
Bone Marrow Transplant; 2002 Nov; 30(9):587-91. PubMed ID: 12407433
[TBL] [Abstract][Full Text] [Related]
13. The Impact of low power laser in the treatment of conditioning-induced oral mucositis: a report of 11 clinical cases and their review.
Antunes HS; Ferreira EM; de Matos VD; Pinheiro CT; Ferreira CG
Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E189-92. PubMed ID: 18305441
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy: the effect of oral cryotherapy on the development of mucositis.
Karagözoğlu S; Filiz Ulusoy M
J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284
[TBL] [Abstract][Full Text] [Related]
15. Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST).
Yamamoto R; Kusumi E; Kami M; Yuji K; Hamaki T; Saito A; Murasgihe N; Hori A; Kim SW; Makimoto A; Ueyama J; Tanosaki R; Miyakoshi S; Mori S; Morinaga S; Heike Y; Taniguchi S; Masuo S; Takaue Y; Mutou Y
Bone Marrow Transplant; 2003 Dec; 32(11):1089-95. PubMed ID: 14625581
[TBL] [Abstract][Full Text] [Related]
16. Oral mucositis.
Scully C; Sonis S; Diz PD
Oral Dis; 2006 May; 12(3):229-41. PubMed ID: 16700732
[TBL] [Abstract][Full Text] [Related]
17. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
[TBL] [Abstract][Full Text] [Related]
18. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
Langner S; Staber P; Schub N; Gramatzki M; Grothe W; Behre G; Rabitsch W; Urban C; Linkesch W; Neumeister P
Bone Marrow Transplant; 2008 Aug; 42(4):275-9. PubMed ID: 18500368
[TBL] [Abstract][Full Text] [Related]
19. [Cryotherapy is useful and safe in the prevention of oral mucositis after high-dose melphalan (L-PAM)].
Inagaki N; Ohue Y; Shigeta H; Tasaka T
Rinsho Ketsueki; 2006 Nov; 47(11):1469-71. PubMed ID: 17176891
[TBL] [Abstract][Full Text] [Related]
20. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
